NCT06452394 2025-12-30
NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline
Swiss Cancer Institute
Phase 2 Recruiting
Clinical Trials
15 trialsNCT02775695 2023-07-03
Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer
Medical College of Wisconsin
Phase 2 Completed
NCT02874430 2022-12-15
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Thomas Jefferson University
Phase 2 Unknown
NCT01874860 2022-12-01
Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients
University of Louisville
Phase 2 Completed
NCT02207556 2021-07-09
DUAL
Medical College of Wisconsin
Phase 2 Completed
NCT02341209 2021-04-27
CTCL
Rochester General Hospital
Phase 2 Terminated
NCT01411202 2020-09-25
OPUS
Ottawa Hospital Research Institute
Phase 2 Unknown
NCT03448731 2020-04-08
DERMIA
Fundacion CRIS de Investigación para Vencer el Cáncer
Phase 2 Completed
NCT01867294 2020-01-09
Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Academic and Community Cancer Research United
Phase 2 Completed
NCT01847976 2019-09-06
OTT12-05
Ottawa Hospital Research Institute
Phase 2 Completed
NCT01677286 2017-08-01
Safety and Effect of Doxycycline in Patients With Amyloidosis
Boston University
Phase 2 Completed
NCT02086591 2016-12-22
A Phase II Study of Doxycycline in Relapsed NHL
University of Rochester
Phase 2 Terminated
NCT01668498 2016-04-19
Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer
AIO-Studien-gGmbH
Phase 2 Completed
NCT00830401 2015-06-04
The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases
UMC Utrecht
Phase 2 Terminated
NCT01010295 2013-11-25
IELSG27
International Extranodal Lymphoma Study Group (IELSG)
Phase 2 Completed